M.-H. Ryu

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

Y-K. Kang, Hye Jin Kang, Dae Young Zang et al. · British Journal of Cancer · 2008 · 136 citations · Full text

Medicine, Oncology, Pharmacology +15

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

Narikazu Boku, M.-H. Ryu, D-Y. Oh et al. · Annals of Oncology · 2020 · 124 citations

Medicine, Oncology, Pharmacotherapy +15

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

Dok Hyun Yoon, M.-H. Ryu, Y S Park et al. · British Journal of Cancer · 2012 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation

Dok Hyun Yoon, Baek‐Yeol Ryoo, M.-H. Ryu et al. · Japanese Journal of Clinical Oncology · 2010 · 87 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Docetaxel Monotherapy as a Second-line Treatment after Failure of Fluoropyrimidine and Platinum in Advanced Gastric Cancer: Experience of 154 Patients with Prognostic Factor Analysis

Jae‐Cheol Jo, J.-L. Lee, M.-H. Ryu et al. · Japanese Journal of Clinical Oncology · 2007 · 43 citations

Medicine, Oncology, Pharmacology +12